Target intelligence / Profile preview

TSR3 ribosome maturation factor (TSR3)

Target
TSR3
Molecular classification
Enzyme, RNA modification enzyme, Transferase, Ribosome biogenesis factor, Other
01

Overview

TSR3 ribosome maturation factor (TSR3) is a highly conserved eukaryotic enzyme required for the final maturation steps of 18S rRNA in the cytoplasmic phase of small ribosomal subunit (40S) biogenesis[1][3]. It functions as an aminocarboxypropyltransferase, utilizing S-adenosylmethionine (SAM) as a donor to install a universally conserved chemical modification—N1-methyl-N3-aminocarboxypropyl-pseudouridine (m^1acp^3Ψ)—at a specific site near the P-site of the 18S rRNA[1][3]. This modification is crucial for proper ribosome assembly and ensures the release of fully mature, functionally competent ribosomal subunits[1]. TSR3’s modification activity temporally coordinates the dissociation and binding of other ribosome assembly factors (notably Rio2 and Rio1 kinases), serving as a checkpoint for quality control in ribosome maturation[1]. Loss or inactivation of TSR3 leads to accumulation of immature rRNA precursors and defective ribosomes, affecting protein synthesis and overall cell growth[1][3]. The enzyme is homologous to the SPOUT-class RNA methyltransferases but uniquely transfers an aminocarboxypropyl group rather than a methyl group due to unique features in its SAM binding site[3]. Currently, there are no known drugs that target TSR3, and it is primarily studied as a fundamental factor for ribosome assembly rather than as a therapeutic target.

Other names
18S rRNA aminocarboxypropyltransferaseC16orf42UND313LHsTsr3MGC2438120S rRNA accumulation protein 3 homologprobable ribosome biogenesis protein C16orf42ribosome biogenesis protein TSR3 homolog
02

Mechanism of action

Not therapeutically targeted; mechanism is transfer of an aminocarboxypropyl group (from S-adenosylmethionine donor) to pseudouridine in 18S rRNA during ribosome assembly

03

Biological functions

rRNA modification (specifically, aminocarboxypropyl transfer to 18S rRNA)Ribosome assembly and maturationLate-stage small subunit (40S) biogenesisQuality control in ribosome assembly
04

Disease associations

Other (no direct association with cancer, inflammation, or classic disease phenotypes as of current data; central to cell viability through ribosome maturation)
05

Safety considerations

Genetic depletion impairs ribosome biogenesis, which can result in cellular proliferation defects, but no direct drug safety concerns reported
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on TSR3 ribosome maturation factor (TSR3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TSR3 ribosome maturation factor (TSR3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call